We are live on ! Find out more
GTC

Ghost Tree Capital Portfolio holdings

AUM $331M
1-Year Est. Return 70.11%
This Fund
S&P 500
This Quarter Est. Return
+10.35%
1 Year Est. Return
+70.11%
3 Year Est. Return
+265.05%
5 Year Est. Return
+3,034.98%
10 Year Est. Return
+22,104.75%
AUM
$346M
AUM Growth
-$33M
Cap. Flow
-$24.2M
Cap. Flow %
-6.99%
Top 10 Hldgs %
58.05%
Holding
59
New
16
Increased
15
Reduced
9
Closed
13

Top Buys

Rank Stock Value
1
SRPT icon
Sarepta Therapeutics
SRPT
+$9.88M
2
ASND icon
Ascendis Pharma A/S
ASND
+$9.34M
3
FOLD
Amicus Therapeutics
FOLD
+$8.74M
4
MRSN
Mersana Therapeutics
MRSN
+$8.59M
5
VRNA
Verona Pharma
VRNA
+$5.57M

Top Sells

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$20.4M
2
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$13M
3
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
+$12.8M
4
TGTX icon
TG Therapeutics
TGTX
+$9.2M
5
AXSM icon
Axsome Therapeutics
AXSM
+$8.23M

Sector Composition

Rank Sector Weight
1 Healthcare 77.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
51
Gilead Sciences
GILD
$167B
– –
-25,000
Closed -$1.92M
KNSA icon
52
Kiniksa Pharmaceuticals
KNSA
$4.92B
– –
-50,000
Closed -$1.27M
PYPD icon
53
PolyPid
PYPD
$103M
– –
-3,333
Closed -$1.8M
QQQ icon
54
PUT
Invesco QQQ Trust
QQQ
$466B
– –
-50,000
Closed -$12.4M
RNAC icon
55
Cartesian Therapeutics
RNAC
$243M
– –
-33,333
Closed -$2.84M
SPY icon
56
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
– –
-65,000
Closed -$20M
VRAY
57
DELISTED
ViewRay, Inc.
VRAY
– –
-300,000
Closed -$672K
IMMU
58
DELISTED
Immunomedics Inc
IMMU
– –
-575,000
Closed -$20.4M
MNTA
59
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
– –
-385,000
Closed -$12.8M
1 2
3

Similar funds

SF
Susquehanna Foundation Bala Cynwyd, Pennsylvania $333M AUM 35.73% 1-Year Est. Return
AFS
Annapolis Financial Services Annapolis, Maryland $338M AUM 23.49% 1-Year Est. Return
SFA
Source Financial Advisors New York $338M AUM 33.62% 1-Year Est. Return
E
ETFidea Syracuse, New York $316M AUM 29.57% 1-Year Est. Return
OHCM
Oak Hill Capital Management New York $310M AUM 17.23% 1-Year Est. Return
MC
Minot Capital Broomfield, Colorado $353M AUM 25.25% 1-Year Est. Return
BRA
Biechele Royce Advisors Fishers, Indiana $303M AUM 20.64% 1-Year Est. Return
S
Syntrinsic Denver, Colorado $301M AUM 27.27% 1-Year Est. Return

Ghost Tree Capital's Q3 2020 Portfolio in Review

As of Q3 2020, Ghost Tree Capital held 59 positions worth $346M, down 8.7% from $379M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Ghost Tree Capital withdrew a net $24.2M in Q3 2020, closing 13 positions and reducing 9 holdings. Its most notable exit was Immunomedics Inc, an estimated $20.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 77% of assets, up from 71% a quarter earlier.

Against the trend, Ghost Tree Capital opened a new position in Sarepta Therapeutics worth $9.13M.

  • Ghost Tree Capital's largest Q3 2020 buy was Sarepta Therapeutics: 65,000 shares worth $9.13M.
  • Ghost Tree Capital added most to Ascendis Pharma A/S in Q3 2020, an estimated $9.34M increase.
  • Ghost Tree Capital's biggest Q3 2020 reduction was Mirati Therapeutics, Inc. Common Stock, cutting an estimated $13M.
  • Ghost Tree Capital fully exited Immunomedics Inc in Q3 2020, selling an estimated $20.4M.
  • Ghost Tree Capital's ten largest holdings make up 58% of its $346M portfolio in Q3 2020.
  • Ghost Tree Capital opened 16 new positions and closed 13 in Q3 2020.
  • Ghost Tree Capital's portfolio value fell 8.7% quarter-over-quarter to $346M.

Based on Ghost Tree Capital's 13F filing for Q3 2020, filed 16 Nov 2020.